Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation--a real patient data analysis in a Hong Kong teaching hospital.

@article{Chang2013CosteffectivenessOD,
  title={Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation--a real patient data analysis in a Hong Kong teaching hospital.},
  author={Andy M Chang and Jason C S Ho and Bryan P Y Yan and Cheuk Man Yu and Yat Yin Lam and Vivian Wing Yan Lee},
  journal={Clinical cardiology},
  year={2013},
  volume={36 5},
  pages={
          280-5
        }
}
BACKGROUND To compare the management cost and cost-effectiveness of dabigatran with warfarin in patients with nonvalvular atrial fibrillation (AF) from the hospital's and patients' perspectives. HYPOTHESIS Dabigatran is more cost-effective than warfarin for stroke prevention of AF in Hong Kong. METHODS The analysis was performed in conjunction with a drug utilization evaluation of dabigatran study in a teaching hospital in Hong Kong. The study recruited 244 patients who received either… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation.

  • Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
  • 2015
VIEW 2 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review.

  • Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND